Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp Operating Expenses

The Total Operating Expenses of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Oct 15, 2026 is 518.38 M CNY. In the previous year, Total Operating Expenses was 527.16 M CNY — a change of -1.66% (lower).

Operating Expenses

518.38 MCNY

YoY

-1.66%

Last updated:

Total Operating Expenses of Vcanbio Cell & Gene Engineering Corp is 2025 518.38 M CNY. Total Operating Expenses of Vcanbio Cell & Gene Engineering Corp was 2024 527.16 M CNY. It decreases by -1.66% lower compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
424.55 M CNY
Jan 1, 2019
396.67 M CNY
Jan 1, 2020
434.60 M CNY
Jan 1, 2021
476.38 M CNY
Jan 1, 2022
476.91 M CNY
Jan 1, 2023
530.34 M CNY
Jan 1, 2024
527.16 M CNY
Jan 1, 2025
518.38 M CNY
The Vcanbio Cell & Gene Engineering Corp Operating Expenses history
YEAROperating ExpensesYoY
518.38 MCNY-1.66%
527.16 MCNY-0.60%
530.34 MCNY+11.20%
476.91 MCNY+0.11%
476.38 MCNY+9.61%
434.60 MCNY+9.56%
396.67 MCNY-6.57%
424.55 MCNY-6.83%
455.66 MCNY+55.60%
292.85 MCNY+14.22%
256.39 MCNY+20.68%
212.46 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp Ltd is a biotechnology company based in Tianjin, China, operating within the healthcare sector. The company has been publicly traded since its IPO on May 4, 1993, and is listed under the ticker 600645.SS with ISIN CNE000000545. It employs 2,332 full-time staff and focuses on the development of life sciences technology. Vcanbio engages in cell culture, gene detection, and storage services, as well as the production and sale of cytokines culture solutions, cosmetics, and detection reagents. The company primarily serves domestic markets in China, with its headquarters located in Tianjin. Its website is http://www.vcanbio.com. The firm's business activities include the development and application of biotechnology solutions, though specific details on product names, acquisitions, or additional financial figures are not provided in the available information. Vcanbio operates as a public company with a presence in the Chinese biotechnology industry, emphasizing innovation in cell and gene engineering. Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

Total Operating Expenses of Vcanbio Cell & Gene Engineering Corp is 518.38 M CNY in 2025.

Total Operating Expenses of Vcanbio Cell & Gene Engineering Corp changed from 527.16 M CNY to 518.38 M CNY, representing a -1.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Vcanbio Cell & Gene Engineering Corp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Vcanbio Cell & Gene Engineering Corp

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vcanbio Cell & Gene Engineering Corp